Superworth

Rockwell Medical EPS RMTI

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$1.34
Latest quarter, Q2 FY26
−$0.34
Fiscal year 2025
−$1.50

Rockwell Medical's earnings per share was −$1.34 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.34.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.50n/a
FY2024−$0.40n/a
FY2023−$4.10n/a
FY2022−$17.00n/a
FY2021−$38.40n/a
FY2020−$45.10n/a
FY2019−$61.60n/a
FY2018−$67.10n/a
FY2017−$56.10n/a
FY2016−$44.00n/a
FY2015−$31.90n/a
FY2014−$57.20n/a
FY2013−$181.50n/a
FY2012−$290.40n/a
FY2011−$132.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.34n/a−$1.34
Q1 FY26−$0.40n/a−$1.50
Q4 FY25−$0.10n/a−$1.50
Q3 FY25−$0.50−225%−$1.70
Q2 FY25−$0.50−600%−$0.80
Q1 FY25−$0.40n/a−$0.20
Q4 FY24−$0.30n/a−$0.40
Q3 FY24$0.40n/a−$0.70
Q2 FY24$0.10n/a−$1.80
Q1 FY24−$0.60n/a−$3.70
Q4 FY23−$0.60n/a−$4.10
Q3 FY23−$0.70n/a−$5.50

Against its peers

Companies in Drug Manufacturers - General nearest Rockwell Medical's size, closest first, today.

CompanyEPS, 12 monthsGrowth
RMTIRockwell Medical−$1.34
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Rockwell Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.